Drugs / chromium nicotinate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00152893 | Aug 2002 → Feb 2008 | HIV infectious disease | Johane Allard | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | chromium-nicotinate | “Subjects were randomized to receive either 400 microg/day chromium-nicotinate or placebo for 16 weeks.” PMID 20163347 ↗ Mar 2010 |
| Route | Oral | “Each soft gel capsule of chromium contains 200ug of chromium and patients will take 1 capsule twice a day or its placebo.” NCT00152893 ↗ |